Quince Therapeutics, Inc. (QNCX) Stock Analysis

Quince Therapeutics, Inc. (QNCX) is a publicly traded company in the HEALTHCARE sector. It trades at $1.05, carries a market capitalization of $21.71M. This page summarizes the public market data, fundamentals, and frequently asked questions for QNCX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.05
• Market Cap: $21.71M
• EPS: $-10.50
• 52-Week High: $45.50
• 52-Week Low: $0.79

Market Sentiment

Quince Therapeutics, Inc. currently has a Bullish sentiment score of 0.62.

About Quince Therapeutics, Inc.

Quince Therapeutics, Inc. is a biopharmaceutical innovator headquartered in South San Francisco, California, dedicated to developing precision therapies for rare and debilitating diseases. Leveraging advanced therapeutic platforms and innovative research methodologies, the company addresses critical unmet medical needs to enhance patient quality of life through its targeted treatment portfolio. With a strong and diverse pipeline, Quince Therapeutics is well-positioned for growth and aims to m...

GNG Research Analysis

GNG Research scores Quince Therapeutics, Inc. (QNCX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for QNCX.

Frequently Asked Questions

Does QNCX pay dividends?

Quince Therapeutics, Inc. (QNCX) does not currently pay a regular dividend.

What is QNCX's market cap?

Quince Therapeutics, Inc. (QNCX) has a market capitalization of $21.71M with a current stock price of $1.05.